Brazil vs Tonga: Death rate from Alzheimer's
Brazil
16.29 deaths per 100,000 people
in 2021
Tonga
15.75 deaths per 100,000 people
in 2021
Brazil rank
65th
Tonga rank
66th
Death rate from Alzheimer's over time
- Brazil
- Tonga
How they compare
Brazil currently reports 16.29 deaths per 100,000 people against 15.75 deaths per 100,000 people in Tonga, a difference of 0.54 deaths per 100,000 people.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Tonga ahead.
Brazil ranks 65th and Tonga ranks 66th of 194 countries.
Across the 3 decades both report, Brazil averaged higher in 1 and Tonga in 2.
Head to head by decade
| Decade | Brazil | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.1 deaths per 100,000 people | 11.88 deaths per 100,000 people | 7.78 deaths per 100,000 people | Tonga |
| 2010s | 10.71 deaths per 100,000 people | 13.66 deaths per 100,000 people | 2.95 deaths per 100,000 people | Tonga |
| 2020s | 15.72 deaths per 100,000 people | 15.04 deaths per 100,000 people | 0.68 deaths per 100,000 people | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from alzheimer's, Brazil or Tonga?
- Brazil, at 16.29 deaths per 100,000 people against 15.75 deaths per 100,000 people in Tonga as of 2021.
- What is the difference in death rate from alzheimer's between Brazil and Tonga?
- 0.54 deaths per 100,000 people, with Brazil ahead.
- How many years of comparable data are there for Brazil and Tonga?
- 22 years are reported by both, from 2000 to 2021.
- How do Brazil and Tonga rank globally for death rate from alzheimer's?
- Brazil ranks 65th and Tonga ranks 66th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes, per 100,000 people.